$$ IVOICE INC $$


Seite 1 von 2
Neuester Beitrag: 01.04.08 17:23
Eröffnet am:26.10.06 12:19von: carpediem7Anzahl Beiträge:42
Neuester Beitrag:01.04.08 17:23von: 0815axLeser gesamt:5.698
Forum:Hot-Stocks Leser heute:0
Bewertet mit:
1


 
Seite: <
| 2 >  

564 Postings, 6558 Tage carpediem7$$ IVOICE INC $$

 
  
    #1
1
26.10.06 12:19
kaufen wenn keiner drüber spricht...ariva.de

und verkaufen wenn ... ariva.de

habe heute für 0,03 nachgekauft und mal kurz meinen Einstiegskurs halbiert...ariva.de

Kurs USA 0,061$ PariKurs 0,0488€ ariva.de

Berlin heute 0,03€ ariva.de

über 30% unter Pari... ariva.de  

564 Postings, 6558 Tage carpediem7nach RS böse unter die Räder gekommen...

 
  
    #2
26.10.06 12:27
iVoice\'s Thomas Pharmaceuticals Ltd. Subsidiary To Launch New Version of Acid + All(TM) At National Association of Chain Drug Stores\' Annual Marketplace; Showcase New Black Cherry Flavor to Buyers



MATAWAN, N.J.--(BUSINESS WIRE)--June 15, 2006--Thomas Pharmaceuticals Ltd, a wholly owned subsidiary of iVoice, Inc. (OTCBB:IVOI), announced today that it will present to senior industry executives at the National Association of Chain Drug Stores\' (NACDS) Annual Marketplace Conference scheduled from June 23-27th in San Diego. Thomas Pharmaceuticals will be showcasing the launch of the New Black Cherry flavor of Acid + All(TM) and unveiling two new product lines targeted at today\'s affluent baby boomer market. The presentation will include a sleekly packaged, high-end antacid tablet, Acid + All(TM) , which is changing the over-the-counter pharmaceutical category by offering a highly effective pharmaceutical product within an attractive packaging. Consumers are now able to find Acid + All(TM)\'s chic blue and white tin at their local drugstores.

NACDS is the industry\'s largest trade show attended by 200 retailers, representing 100,000 stores and $540 billion in buying power. At the conference, Thomas\' management will meet with senior executives and division and category managers responsible for bringing new products to drugstore customers. "This is a tremendous opportunity to present Acid + All(TM), the first product in the Thomas Pharmaceuticals Ltd. family of innovative over the counter healthcare products to decision makers and to begin the purchase order process," said Mr. Thomas, President and Founder of Thomas Pharmaceuticals Ltd.

Acid + All(TM), the calcium enriched, spearmint-flavored, sugar free tablets that soothe heartburn, acid indigestion and gas is available at independent pharmacies, major drug chains and online retailers or by calling toll-free at 1-888-922-1959. Acid + All(TM) will be available in a sleek, 32-count pillbox and will retail for approximately $3.89. Thomas Pharmaceutical plans to introduce Acid + All(TM) line extensions later this year along with other new over-the-counter products. For more information about Acid + All(TM) go to www.acidall.com.

About Thomas Pharmaceuticals Ltd:

Thomas Pharmaceuticals Ltd., based in New York, NY, develops and markets over the counter non-prescription healthcare products. The company focuses on high-end, branded consumables. Its first product, Acid + All(TM), is a calcium-enriched, sugar free, anti-gas antacid.

About iVoice, Inc:

iVoice has determined that the best way to create shareholder value, separate and apart from the operating performance of iVoice, is to implement new business opportunities by distributing shares of spin-offs to the company\'s shareholders. The common stock distributions are part of a broader strategy relating to the transition of iVoice into a company focused on the development and licensing of proprietary technologies. We also continue to search for potential merger candidates with or without compatible technology and products, which management feels may make financing more appealing to potential investors.

Certain information included in this press release, may contain forward-looking statements about our current and expected performance trends, growth plans, business goals and other matters. These statements may be contained in our filings with the Securities and Exchange Commission, in our press releases, in other written communications, and in oral statements made by or with the approval of one of our authorized officers. Information set forth in this press release contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995 (the "Act" provides certain "safe harbor" provisions for forward-looking statements. The reader is cautioned that such forward-looking statements are based on information available at the time and/or management\'s good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Forward-looking statements speak only as of the date the statement was made. We assume no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. Forward-looking statements are typically identified by the use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "project," "should," "will," and similar words, although some forward-looking statements are expressed differently. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.

For more information on iVoice, please visit http://www.ivoice.com or http://www.thomaspharmaceuticals.com/


CONTACT: iVoice, Inc.
Investor Relations
Dolores Serafin, 732-441-7700
investors@ivoice.comhttp://www.ivoice.com
or
CEOcast, Inc. for iVoice
Andrew Hellman, 212-732-4300
adhellman@ceocast.com

SOURCE: iVoice, Inc.

 

564 Postings, 6558 Tage carpediem7Meldung zum Reverse Stock Split...

 
  
    #3
26.10.06 12:29
IVOC News

iVoice, Inc., Announces 1-for-200 Reverse Stock Split and Change of Trading Symbol to IVOI
Wednesday April 26, 4:30 pm ET


MATAWAN, N.J.--(BUSINESS WIRE)--April 26, 2006--iVoice, Inc (OTCBB:IVOC - News), announced today that its common stock will split 1-for-200. Each 200 shares of common stock will be converted into one new share of common stock. Shareholders of iVoice may retain their present certificates and do not have to submit them for replacement.
The new trading symbol of iVoice, Inc. will be: IVOI

The shareholders of iVoice, Inc. approved this reverse split at the Company\'s Annual Meeting of Shareholders that was held on March 31, 2006.

The shareholders of iVoice also approved the following proposals:

1. The grant of discretionary authority for the Board of Directors to
declare a cash dividend to Class A Common Stock shareholders of
$1.5 million.

2. The grant of discretionary authority for the Board of Directors to
effect the repurchase of sixty percent (60%) of the issued and
outstanding Class B Common Stock shares for $1.5 million.

3. The re-authorization of 10 billion of Class A Common Stock.

4. The grant of discretionary authority for the Board of Directors to
effect the buyback by the Company of up to $1 million of the Class
A Common Stock.

7. The re-election of two members of the Board of Directors: Jerome
Mahoney and Frank Esser

8. Approval of the iVoice, Inc. 2005 Stock Incentive Plan.

9. The ratification our Board of Directors\' selection of Bagell
Josephs Levine & Company, LCC to audit our financial statements
for the fiscal year ending December 31, 2005.

10. The grant of discretionary authority for the Board of Directors to
file an amendment to our Certificate of Incorporation to change
our name to ARX Emerge, Inc.

About iVoice, Inc.

iVoice has determined that the best way to create shareholder value, separate and apart from the operating performance of iVoice, is to implement new business opportunities by distributing shares of spin-offs to the Company\'s shareholders. The common stock distributions are part of a broader strategy relating to the transition of iVoice into a company focused on the development and licensing of proprietary technologies. We also continue to search for potential merger candidates with or without compatible technology and products, which management feels may offer long term growth prospects to increase shareholder value. For more information, contact CEO Jerry Mahoney at (732) 441 7700 or by e-mail at jerrym@ivoice.com.

Certain information included in this press release, may contain forward-looking statements about our current and expected performance trends, growth plans, business goals and other matters. These statements may be contained in our filings with the Securities and Exchange Commission, in our press releases, in other written communications, and in oral statements made by or with the approval of one of our authorized officers. Information set forth in this press release contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995 (the "Act" provides certain "safe harbor" provisions for forward-looking statements. The reader is cautioned that such forward-looking statements are based on information available at the time and/or management\'s good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Factors that could cause or contribute to such differences include, but are not limited to those risk factors that are set forth in the section entitled "Forward Looking Statements - Cautionary Factors" in the Company\'s Form 10-KSB for fiscal year ended December 31, 2005 and other filings with the Securities and Exchange Commission from time to time. Forward-looking statements speak only as of the date the statement was made. We assume no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. Forward-looking statements are typically identified by the use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "project," "should," "will," and similar words, although some forward-looking statements are expressed differently. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.

For more information on iVoice, please visit http://www.ivoice.com

 

564 Postings, 6558 Tage carpediem7ist die Aktie nicht trotzdem langfristig

 
  
    #4
26.10.06 12:33
interessant? ariva.de

Wäre für eure Meinung sehr dankbar....ariva.de  

564 Postings, 6558 Tage carpediem7nun mal nicht alle auf einmal...

 
  
    #5
26.10.06 13:52

564 Postings, 6558 Tage carpediem7und noch mehr Geschenke...

 
  
    #6
27.10.06 10:55

heute wieder welche zu 0,035...

könnt mir gerne noch mehr "verkaufen"...ariva.de

habe noch Order zu 0,03 drin... für alle Frustrierten...ariva.de

bin ja großzügig... ariva.de

 

2892 Postings, 7125 Tage RockeFällerDer Umsatz heute ist ja der Hammer o. T.

 
  
    #7
27.10.06 11:02

564 Postings, 6558 Tage carpediem7Hehehe...

 
  
    #8
27.10.06 11:05

ariva.de darum geht es doch gar nicht...

ich finde es nur nett, das hier alle ihre Aktien wegschmeißen...nur um die roten Zahlen aus ihrer

Depotübersicht zu bekommen...und das zu über 30% unter Pari...

und falls die Aktie irgendwann mal wieder steigt...

und auch wenn das in 10Jahren ist...dann heulen wieder alle... ariva.de

 

 

564 Postings, 6558 Tage carpediem7verkaufen...

 
  
    #9
06.11.06 11:24
Kurs schmiert ab...

gab "tolle" News...ariva.de  

564 Postings, 6558 Tage carpediem7hier die News....

 
  
    #10
06.11.06 11:28
02.11.06 14:00 (BUSINESS WIRE)
iVoice's Thomas Pharmaceuticals Ltd. Announced Acid + All(TM) Antacid Table Product Line Now in More Than 20,000 Drug Stores Nationwide  

564 Postings, 6558 Tage carpediem7vom 02.11.2006

 
  
    #11
06.11.06 11:29
Thomas Pharmaceuticals Ltd ("Thomas Pharmaceuticals"), a wholly owned subsidiary of iVoice, Inc. (OTCBB:IVOI), announced today that its new upscale antacid tablet product line Acid + All(TM) is now in more than 20,000 pharmacies and drug stores since the launch of the product line approximately six months ago. The stores include leading drugstore chains, such as Rite Aid Corporation which recently reordered the product due to the success of its initial order.

Anzeige:
 www.kleinspekulant.com: Strategie eines Kleinspekulanten und
meine besten Aktien um die Profis zu schlagen. Erfahren Sie mehr...  




"We are pleased that in a short period of time that Acid + All(TM) has enjoyed such success from leading drugstore chains and pharmacies across the country that more than 20,000 of them have elected to carry the product," said Tom Thomas, President and Founder of Thomas Pharmaceuticals. "Despite the rapid adoption of the product, in the coming months we plan to further increase distribution by expanding relationships with drugstore chains such as Rite Aid Corporation and other leading retailers."

Acid + All(TM), the calcium enriched, spearmint-flavored, sugar free tablets that soothe heartburn, acid indigestion and gas is available at independent pharmacies, major drug chains and online retailers or by calling toll-free at 1-888-922-1959. Acid + All(TM) will be available in a sleek, 32-count pillbox and will retail for approximately $3.89. Thomas Pharmaceuticals plans to introduce Acid + All(TM) line extensions later this year along with other new over-the-counter products. For more information about Acid + All(TM) go to www.acidall.com.

About Thomas Pharmaceuticals

Thomas Pharmaceuticals Ltd., based in New York, N.Y., develops and markets over the counter non-prescription healthcare products. The company focuses on high-end, branded consumables. Its first product, Acid + All(TM), is a calcium-enriched, sugar free, anti-gas antacid. On August 9, 2006, iVoice, Inc. entered into a Stock Purchase Agreement dated August 7, 2006 by and among Thomas Pharmaceuticals Ltd.,Thomas Pharmaceutical Acquisition Corp. ("Thomas Acquisition") and iVoice, Inc. whereby Thomas Acquisition has agreed to purchase all of the outstanding securities presently held by iVoice. iVoice may terminate this Stock Purchase Agreement should the closing not have ocurred by October 31, 2006. Thomas Acquisition is substantially controlled by the original founders and management of Thomas Pharmaceuticals.

About iVoice, Inc:

iVoice has determined that the best way to create shareholder value, separate and apart from the operating performance of iVoice, is to implement new business opportunities by distributing shares of spin-offs to the company's shareholders. The common stock distributions are part of a broader strategy relating to the transition of iVoice into a company focused on the development and licensing of proprietary technologies. We also continue to search for potential merger candidates with or without compatible technology and products, which management feels may make financing more appealing to potential investors.

Certain information included in this press release, may contain forward-looking statements about our current and expected performance trends, growth plans, business goals and other matters. These statements may be contained in our filings with the Securities and Exchange Commission, in our press releases, in other written communications, and in oral statements made by or with the approval of one of our authorized officers. Information set forth in this press release contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995 (the "Act") provides certain "safe harbor" provisions for forward-looking statements. The reader is cautioned that such forward-looking statements are based on information available at the time and/or management's good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Forward-looking statements speak only as of the date the statement was made. We assume no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. Forward-looking statements are typically identified by the use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "project," "should," "will," and similar words, although some forward-looking statements are expressed differently. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.

For more information on iVoice, please visit http://www.ivoice.com or http://www.thomaspharmaceuticals.com/.
 

564 Postings, 6558 Tage carpediem7gestern +48% in USA

 
  
    #12
28.11.06 11:39
und über 1,3 Mil. gehandelte Aktien...im Vergleich zu den Tagen vorher ein
sehr hoher Umsatz...

vielleicht kommt ja langsam Bewegung rein...

;-))  

564 Postings, 6558 Tage carpediem7die Hoffnung stirbt zuletzt...

 
  
    #13
23.02.07 14:17
und ich bin dabei... ;-)  

3026 Postings, 6990 Tage TifflorBin nun dabei RT 0,0076 + 442 %

 
  
    #14
09.10.07 20:57
 

268 Postings, 6547 Tage admiral_rwas ist denn da los

 
  
    #15
09.10.07 21:03
gab es news  

3026 Postings, 6990 Tage TifflorJa hier sind sie

 
  
    #16
09.10.07 21:37
October 9, 2007 - 5:07 AM EST          

close Email this News Article  
Your Name  
Your Email  
Friend's Name  
Friend's Email  
Receive Copy: yes                
 
IVOI 0.0073   0.0059  

Today 5d 1m 3m 1y 5y 10y



iVoice, Inc., Announces Record Date for Spin-Off of Thomas Pharmaceuticals Ltd. To Shareholders
Fifth Spin-Off and Fifth Stock Dividend to the Shareholders


iVoice, Inc. (OTC Bulletin Board: IVOI), announced today the record date of October 15, 2007 for the pending spin-off in the form of a special dividend of its wholly owned subsidiary, Thomas Pharmaceuticals Ltd. (“Thomas Pharmaceuticals”).

Each iVoice shareholder as of the record as of October 15, 2007 will receive shares of Thomas Pharmaceuticals subject to: (i) the record having passed, (ii) the Securities and Exchange Commission reviewing and approving the final amendment to the Thomas Pharmaceuticals’ Form SB-2/A and (iii) declaration of effectiveness of this registration statement by the Securities and Exchange Commission. In order to receive shares in Thomas Pharmaceuticals, you must own shares of iVoice, Inc. on the record date of October 15, 2007. It is anticipated that the distribution in the form of a special dividend of Thomas Pharmaceuticals shares will occur sometime in November 2007. Following the distribution, Thomas Pharmaceuticals plans to have its shares traded on the NASD OTC Bulletin Board.

About iVoice, Inc:

iVoice has determined that the best way to create shareholder value, separate and apart from the operating performance of iVoice, is to implement new business opportunities by distributing shares of spin-offs to the Company's shareholders. The common stock distributions are part of a broader strategy relating to the transition of iVoice into a company focused on the development and licensing of proprietary technologies. We also continue to search for potential merger candidates with or without compatible technology and products, which management feels may make financing more appealing to potential investors.

Certain information included in this press release, may contain forward-looking statements about our current and expected performance trends, growth plans, business goals and other matters. These statements may be contained in our filings with the Securities and Exchange Commission, in our press releases, in other written communications, and in oral statements made by or with the approval of one of our authorized officers. Information set forth in this press release contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995 (the "Act") provides certain "safe harbor" provisions for forward-looking statements. The reader is cautioned that such forward-looking statements are based on information available at the time and/or management's good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Forward-looking statements speak only as of the date the statement was made. We assume no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. Forward-looking statements are typically identified by the use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "project," "should," "will," and similar words, although some forward-looking statements are expressed differently. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.

For more information on iVoice, please visit http://www.ivoice.com

 

3026 Postings, 6990 Tage TifflorSK 0,0096 +585%

 
  
    #17
09.10.07 22:12
Sollte morgen weiter nach oben laufen.

Schauen wir mal aber es sieht sehr gut aus ;-)  

941 Postings, 6127 Tage kadmonsei so nett,

 
  
    #18
09.10.07 22:20
kannst mir mal kurz erklären was hier abgeht? hab jetzt gekauft, weiß aber nicht so genau was los ist? mein englisch reicht einfach nicht aus um die news zu verstehen. vielen dank!  

941 Postings, 6127 Tage kadmon@Tifflor

 
  
    #19
09.10.07 22:22
dich frag ich um rat! danke  

3026 Postings, 6990 Tage TifflorSieht gut für heute aus !

 
  
    #20
10.10.07 11:26
@ Kadmon

Ist ne heisse Sache - Jedenfalls geht es um Dividende ( spin off ).
Man bekommt Aktien von einer Tochterfirma wenn man am
15. October (record date) Aktien von IVOICE hat.

Hier müssten nun noch neue Infos kommen zu dem spin off.
Halt noch einiges nach oben drin aber heiss ;-)





 

3026 Postings, 6990 Tage Tifflor400 % eben in Berlin *wahnsinn*

 
  
    #21
10.10.07 11:44
 

3026 Postings, 6990 Tage TifflorDas Teil ist einfach wahnsinn

 
  
    #22
10.10.07 16:18
 

4951 Postings, 5984 Tage 0815axguter Rat ist teuer?!

 
  
    #23
12.10.07 19:37
...ziemliche Kursschwankungen - NEWS negativ oder positiv aufgefasst??
Trage mich mit dem Gedanken, diese Aktie in mein Depot zu legen.
Hat jemand weitere Hintergrundinformationen?...

ciao ax  

4951 Postings, 5984 Tage 0815axKursentwicklung ??

 
  
    #24
13.10.07 08:49
...letzter Umsatz gestern in Berlin:
VK 766.666 (zu 0.004) => dadurch Tagesendkurs 0.003

Gewinnmitnahme (0.003 nach 0.004 zu 0.003) oder tendenzielle Entwicklung wieder gen 0.001 ???

Tifflor - wie siehst du es ?...

ciao ax  

4951 Postings, 5984 Tage 0815axNews 24.10.07 (engl)

 
  
    #25
24.10.07 18:35

Seite: <
| 2 >  
   Antwort einfügen - nach oben